Drugs with this side effect
- 1,25(OH)2D3
- 17-hydroxyprogesterone: postmarketing
- 18F-flutemetamol: 1%
- 2-hydroxysuccinaldehyde: 5% - 18%
- 4-AP: 7%
- 4-PBA: common
- 4-methylpyrazole: 14%
- 5-ASA: postmarketing, rare, 2% - 53%
- 5-FU: 1%
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine: 13.6% - 27.7%
- 5-azacytidine: very common, 10.9% - 21.8%
- 5-fluorocytosine
- 8-MOP
- A77 1726: 19%
- ACTH(1-39: postmarketing
- ALX 111
- AMD3100: common, 0% - 22%
- APAs
- Abarelix: 12.3%
- Anidulafungin: 0.997% - 8.4%
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU: 1-10% - 27.5%
- Benicar-HCT
- Bivalirudin: postmarketing, 0.2% - 12.2%
- CAS 76095-16-4: 1.8% - 5.2%
- CAS 76420-72-9
- CGP 19835A: very common, 50%
- Cancidas: 0% - 19.1%
- Cantril
- Carfilzomib: 0% - 27.6%
- Colimycin M
- D-cycloserine
- DFMO: 3.8% - 5%
- Depreotide
- Diane-35
- EACA
- EDTA
- Enfuvirtide
- Eptifibatide: 3.2%
- Estrofem
- FAMP: 0% - 3%
- FK463: 2% - 5.7%
- FP-CIT: common
- FTY720: very common, 25% - 25.2%
- FdUrd
- Fe(III: postmarketing, 0% - 24%
- Forteo: 7.5%
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: postmarketing, 11% - 44%
- Goserelin: postmarketing, 0% - 75%
- Histrelin: postmarketing
- Hoe 140
- Humalog: 8.82% - 29.6%
- ICI 182,780: postmarketing, 6.68% - 16.8%
- Implanon: 1.6% - 24.9%
- Insulin: 0.468% - 11.2%
- K779: 1% - 62%
- Kaluril
- L-Dmp
- L-threo-DOPS: 6.11% - 13.2%
- LMWH: postmarketing
- LY146032: postmarketing, common, 5.4% - 10.3%
- Lantus: 4.15% - 10.3%
- Leuprorelin: postmarketing, 2% - 7%
- LiOH
- Lisinopril: postmarketing, common, 4.4% - 5.6%
- Lu AA21004
- Lutalyse
- Lyxumia
- MDV3100: 0.9% - 12.1%
- MK-462
- Meropenem anhydrous: 2.3% - 7.8%
- Metrodin: postmarketing, very common, 1.05% - 26.5%
- MnDPDP
- N-carbamylglutamate
- N-methylscopolamine
- NTBC
- Nafarelin: postmarketing, 19%
- NovoLog: 3% - 35%
- NuvaRing
- Nuvocid: 6.71% - 7.07%
- Octreotide: very common, 13.3% - 18.4%
- Oestrogen: uncommon, 0.575% - 38%
- Optison: postmarketing, common, 2% - 5.4%
- Org 37462: uncommon, 0.4%
- PCI-32765: 0% - 14%
- PEP005: common, 1.11% - 2.19%
- PGE1: 1.31% - 37%
- PGE2
- Paroven
- Photofrin: 2.02% - 8.7%
- Photofrin II: common
- Prednefrin
- Promacta
- Protirelin
- Refludan
- Romidepsin: 0% - 34%
- SOM230: 28% - 28.7%
- SU5416
- Saxagliptin: 5.18% - 6.5%
- Signifor: 28% - 28.7%
- SonoVue
- Stalevo 50
- Supremon: 16.5% - 28.5%
- Symlin
- T-A2-3
- TMC207: 27.8%
- TMC435: 21%
- TPGS
- TR-700: 6%
- Tadenan
- Terlipressin: postmarketing
- Triphasil
- Triptorelin: postmarketing, 1.7% - 7.5%
- Trisequens
- UDCA: postmarketing, 18.1% - 24.8%
- VACV: postmarketing, common, 2% - 62%
- Vancocine
- Vitrum
- abacavir: common, 5.44% - 31.3%
- abacavir-lamivudine: common
- acamprosate: frequent
- acebutolol: 4% - 13%
- acetaminophen: 1.3% - 9.7%
- acetazolamide
- acetohydroxamic acid
- acipimox
- acitretin: postmarketing
- aclidinium bromide: 6.6%
- acyclovir: common, 0.9% - 5.9%
- adefovir: 9%
- adefovir dipivoxil: postmarketing, common, 9%
- adenosine: 2% - 18%
- afatinib: 0% - 14%
- agomelatine
- albendazole: 1.3% - 11%
- alcaftadine
- alendronate: 0% - 2.6%
- alfentanil
- alfuzosin: common, 1.4% - 2.96%
- aliskiren: 6.71% - 11.2%
- allopurinol
- almotriptan: frequent, 1% - 2%
- alogliptin: 4.19% - 5.36%
- alosetron: postmarketing
- alpha-methyl-p-tyrosine
- alprazolam: frequent, 1.1% - 29.2%
- amantadine: uncommon, common
- ambrisentan: very common, 14.6% - 19.4%
- amikacin
- amiloride: 7.6%
- aminoglutethimide
- aminophylline
- amiodarone
- amisulpride: 3%
- amitriptyline
- amlexanox: 0% - 1.47%
- amlodipine: 7.3%
- amlodipine besylate: 7.3%
- amobarbital
- amoxapine
- amoxicillin: 0.98% - 7%
- amphetamine
- amphotericin B: 19.8% - 20.9%
- amprenavir: very common, 2% - 4%
- amsacrine: 1-10%
- anagrelide: 43.5% - 45%
- anastrozole: 7.83% - 18%
- anthracycline: 2% - 23%
- apomorphine
- apraclonidine: postmarketing
- apremilast: 1.2% - 5.88%
- aprepitant: 1.8% - 16.4%
- argatroban: 5.4% - 5.5%
- arginine
- aripiprazole: 7% - 32%
- arsenic
- arsenic trioxide: very common
- articaine
- asenapine: 3.99% - 12%
- atazanavir: common, 1% - 11%
- atenolol: postmarketing
- atomoxetine: very common, 3% - 27%
- atorvastatin: 2.5% - 16.7%
- atosiban
- atovaquone: 16% - 31%
- atropine
- avanafil: 5.1% - 12.1%
- axitinib: 0% - 14%
- azathioprine
- azelastine: 1.44% - 14.8%
- azithromycin: postmarketing, 0% - 5.5%
- aztreonam
- baclofen: uncommon, common, 0% - 10.7%
- balsalazide: 8% - 15.2%
- beclomethasone: 2.26% - 25%
- beclomethasone dipropionate
- beclomethasone monopropionate: 8% - 25%
- belinostat: 0% - 15%
- benazepril: 0.6% - 6.2%
- benazeprilat: 0.6% - 6.2%
- bendamustine: 0%
- benzathine penicillin
- benzonatate
- benzphetamine
- benzydamine
- bepotastine
- bepridil: 6.98% - 13.6%
- besifloxacin
- betahistine: common
- betaine
- betaxolol: postmarketing, 4.1% - 14.8%
- bethanechol
- bexarotene: very common, 0% - 41.5%
- bezafibrate: 4%
- bicalutamide: 4%
- bimatoprost: common
- bisacodyl
- bisoprolol: postmarketing, common, 8.3% - 10.9%
- boceprevir: very common, 48%
- bortezomib: 0% - 27.6%
- bosentan: 11.5% - 39%
- bosutinib
- brimonidine: very common, 2.4% - 17%
- brinzolamide: postmarketing, 0.5% - 1.3%
- bromazepam: postmarketing, 1%
- bromcresol green
- bromfenac
- bromocriptine: postmarketing, common, 10% - 19%
- budesonide: postmarketing, 11.4% - 28%
- bumetanide: 0.6%
- bupivacaine: 0% - 7%
- buprenorphine: 3% - 36.4%
- bupropion: postmarketing, frequent, 1.1% - 34%
- buspirone: 6%
- busulfan: 69%
- butabarbital
- butorphanol
- cabazitaxel: 0%
- cabergoline: 3.5% - 26.8%
- cabozantinib: 0% - 18%
- candesartan: 0.6%
- candesartan cilexetil: 0.6% - 10.9%
- capecitabine: 1% - 15%
- capsaicin
- captopril
- carbachol
- carbamazepine: postmarketing, common, 3.23% - 22%
- carbenicillin
- carbidopa: 1.9% - 2%
- carbimazole
- carbinoxamine
- carboprost
- carisoprodol: postmarketing, 3.23% - 4.74%
- carnitine: 3% - 37%
- carteolol
- carvedilol: 0.3% - 8.1%
- cefaclor: rare, 2.67% - 5.44%
- cefadroxil
- cefazolin
- cefdinir
- cefditoren
- cefepime: 1%
- cefixime: postmarketing, 11%
- cefotaxime
- cefpodoxime
- cefprozil
- ceftaroline
- ceftazidime: uncommon
- ceftobiprole: 4.5%
- ceftriaxone: 0.1 - 1.0%
- cefuroxime
- cefuroxime axetil
- celecoxib: 10% - 20.2%
- celiprolol
- cephalexin
- cephem
- cerivastatin: 8.5%
- cetirizine: 0.65% - 16.5%
- cetrorelix: 0% - 8.14%
- cevimeline: 14.4%
- chloramphenicol
- chlorhexidine
- chloroprocaine
- chlorpheniramine
- chlorpropamide
- chlorthalidone: rare
- choline theophyllinate
- ciclesonide: 0.4% - 11%
- ciclopirox
- cidofovir: postmarketing, common, very common, 29.6%
- cilazapril: postmarketing, 3.2% - 5.1%
- cilostazol: 27% - 34%
- cimetidine: common, 3.1%
- cinacalcet: 0% - 20.7%
- cinoxacin
- ciprofloxacin: uncommon, 1% - 3%
- citalopram: 24% - 26.9%
- cladribine: very common, 7% - 22%
- clarithromycin: postmarketing, common, 1.6% - 5%
- clemastine
- clevidipine: 6.3%
- clindamycin: 0.649% - 7.06%
- clindamycin phosphate
- clobazam: 3.6%
- clobetasol: 0.787% - 1.79%
- clobetasol propionate
- clofarabine: very common, 24%
- clofazimine
- clomiphene citrate: 1% - 1.3%
- clomipramine: common, very common, 28% - 52%
- clonazepam
- clonidine: 1% - 29%
- clopidogrel: postmarketing, uncommon
- clorazepate
- clozapine: 7% - 10%
- cobicistat: common
- colchicine: 1.35% - 1.92%
- colesevelam: common, 3.88% - 7.6%
- colestimide: uncommon
- colestipol
- colestyramine
- conivaptan: 3.3%
- conjugated estrogens: postmarketing, 2.14% - 3.5%
- copolymer 1
- cortisol
- cortisone
- cosyntropin
- cyanocobalamin
- cyclizine
- cyclobenzaprine: 5% - 17%
- cyclophosphamide: postmarketing
- cyproheptadine
- cyproterone
- cyproterone acetate: very rare, common
- cysteamine: common, 0% - 9%
- cytarabine: 2% - 56.4%
- dabigatran etexilate
- dabrafenib: very common, 0% - 37%
- dacarbazine: 1%
- dalbavancin: 4.67% - 4.82%
- dalteparin: 1.72% - 1.73%
- danazol
- dantrolene: 3.33% - 12.9%
- dapagliflozin
- dapsone: 4%
- darifenacin: 4.45% - 6.72%
- darunavir: 0.9% - 9%
- dasatinib: very common, 0% - 33%
- deferasirox: common
- deferiprone
- deferoxamine: common
- degarelix
- delamanid
- delavirdine
- delta 9-THC: postmarketing
- demeclocycline
- demethyl
- deprenyl: postmarketing, 2% - 18%
- desflurane: 1%
- desipramine
- desloratadine: 0.6% - 4.5%
- desmopressin: 1% - 27%
- desogestrel
- desonide: 0.515% - 1.81%
- desvenlafaxine: 20%
- dexamethasone: 2.41% - 3.82%
- dexamethasone sodium phosphate
- dexmedetomidine: postmarketing
- dexrazoxane
- diatrizoate
- diazepam
- diazoxide
- dichlorphenamide
- diclofenac: postmarketing, common, 0% - 32.7%
- dicyclomine: postmarketing
- didanosine
- diethylenetriaminepentaacetic acid
- diethylpropion
- diflunisal
- digoxin: 3.25% - 4%
- dihydrocodeine: uncommon
- dihydroergotamine: postmarketing
- diltiazem: 2.1% - 17%
- dimenhydrinate
- dimercaprol
- dimercaptosuccinic acid
- diphenhydramine
- dipyridamole: 2.3% - 12.2%
- disopyramide
- disulfiram
- dobutamine
- docetaxel: 1% - 8%
- dofetilide: 11%
- dolasetron: 7.02% - 41.1%
- dolutegravir: 1% - 14%
- domperidone
- donepezil: 3% - 10%
- dopamine
- doripenem: very common, 3% - 16%
- dorzolamide
- dothiepin
- doxapram
- doxazosin: 0% - 16.5%
- doxepin: 0.909% - 4.19%
- doxercalciferol: 27.9%
- doxorubicin: common, 0% - 14.9%
- doxycycline: postmarketing, 2.03% - 28.1%
- doxycycline hyclate: 25.8%
- duloxetine: very common, 9% - 20%
- dyphylline
- ecallantide: 8% - 16%
- efavirenz: common, 0% - 11%
- eletriptan: 3% - 4%
- eliglustat: 1.89% - 40%
- eltrombopag: 10% - 21%
- elvitegravir: common
- emedastine: 11%
- emtricitabine: postmarketing, very common, 5% - 10.2%
- entacapone: 3.5%
- entecavir: common, 1% - 9%
- ephedrine
- epinastine
- epitopic
- eplerenone: uncommon
- eprosartan
- ergonovine
- eribulin: 1% - 19%
- erlotinib: 17%
- ertapenem: 0% - 6.9%
- eslicarbazepine
- eslicarbazepine acetate
- esmolol: 3%
- esomeprazole magnesium: 1.9% - 8.1%
- estazolam: 16%
- estradiol: postmarketing, common, 5% - 50%
- estradiol cypionate
- estradiol valerate
- estramustine: 1%
- estramustine phosphate
- estrone
- ethacrynic acid
- ethambutol
- ethionamide
- ethosuximide
- ethotoin
- etidronate: postmarketing
- etodolac: postmarketing
- etoposide
- etoricoxib
- etravirine: 2.7%
- everolimus: common, very common, 0% - 30%
- exemestane: very common, 1.5% - 8-19%
- exenatide: 4.24% - 14%
- ezetimibe: postmarketing, common, 1.3% - 8%
- famciclovir: postmarketing, rare, very common, 5.3% - 39.3%
- famotidine: 4.6% - 6.9%
- febuxostat
- felbamate: 6.5% - 36.8%
- felodipine
- fenofibrate: postmarketing, rare, 0.533% - 16.7%
- fenofibric acid: postmarketing, 3.2% - 16.7%
- fenoldopam
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 20%
- ferumoxytol: postmarketing, 1.8% - 2.1%
- fesoterodine: postmarketing
- fexofenadine: 1.7% - 10.6%
- fidaxomicin
- finasteride: 2% - 12.1%
- flavoxate
- flecainide: 4.5% - 9.6%
- florbetapir: common, 1.8%
- flucloxacillin
- fluconazole: uncommon, common, 1.9% - 13%
- fludarabine: 0% - 9%
- fludrocortisone
- fludrocortisone acetate
- flumazenil
- flunisolide: 8.8% - 13.8%
- flunitrazepam: common
- fluocinolone acetonide: 31% - 33%
- fluocinonide: postmarketing, 2.84% - 3.96%
- fluorescein: postmarketing, uncommon
- fluoxetine: very rare, very common, 13% - 32.6%
- fluoxymesterone
- fluphenazine
- fluphenazine decanoate
- flurazepam
- flurbiprofen
- flutamide
- fluticasone: 1.81% - 16.1%
- fluticasone furoate: postmarketing, common, 7.51% - 8.33%
- fluticasone propionate: postmarketing, common, 1.2% - 16.1%
- fluticasone/salmeterol: very common
- fluvastatin: common, 0.9% - 8.9%
- fluvoxamine: common, frequent, 2% - 35%
- fondaparinux: rare, 1.43% - 4.53%
- formoterol: common, 8% - 30%
- fosamprenavir: common
- fosaprepitant
- fosaprepitant dimeglumine: 5% - 6.5%
- foscarnet
- fosfomycin: 3.4% - 5.9%
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: 2.2% - 8.9%
- fospropofol
- frovatriptan
- furosemide
- fusidic acid: 1% - 1.5%
- gabapentin: postmarketing, 3.1% - 45%
- gadobenate dimeglumine: 0.8% - 5.8%
- gadobutrol: 0.9% - 1.1%
- gadodiamide
- gadofosveset
- gadolinium: 0.5% - 9.4%
- gadopentetate: 4.8%
- gadoteridol: 0.68%
- gadoversetamide: 4.87% - 9.42%
- galantamine: 7.6% - 8%
- ganciclovir: 6% - 27%
- gatifloxacin: postmarketing
- gemcitabine: very common, 0% - 7%
- gemeprost
- gemfibrozil: 1.2% - 2.3%
- gemifloxacin: 1.2% - 1.5%
- gentamicin
- glibenclamide
- gliclazide: 3.8% - 4.6%
- glimepiride: 1.5% - 11%
- glipizide: 8.6%
- glucose
- glutamine: 6.25% - 11.1%
- glycerol phenylbutyrate: 8.89% - 13.6%
- glycopyrrolate: common, 15%
- gonadorelin: common, 4.65% - 10.2%
- granisetron: 0.7% - 21%
- griseofulvin
- guaifenesin
- guanfacine: postmarketing, 0.2% - 24%
- halofantrine: 3% - 5%
- haloperidol: very rare, postmarketing
- heparin: postmarketing
- hepatitis B vaccines: common
- hetastarch: postmarketing
- histamine
- hydralazine: common, very common
- hydrochlorothiazide
- hydrocodone: 0% - 3.73%
- hydroflumethiazide
- hydromorphone: 5.22% - 12.4%
- hydroxocobalamin
- hydroxybutyrate: postmarketing, 9% - 31%
- hydroxychloroquine
- hydroxyurea: common, 1%
- hydroxyzine
- ibandronate: 2.6% - 7%
- ibuprofen: 8.96% - 27%
- ibutilide: 3.6%
- icodextrin: 7% - 9%
- idarubicin: 20% - 24%
- iloprost: 30%
- imatinib: very common, 0% - 43.3%
- imipramine: common
- imiquimod: common, 0.4% - 8%
- indacaterol: postmarketing, common, 3.7% - 5.12%
- indapamide: 3.4% - 17%
- indinavir: 5.1% - 25.2%
- indomethacin: 11% - 16%
- insulin detemir: 5.3% - 32.2%
- iodide
- iodipamide
- iodixanol: 2.3% - 11.3%
- iohexol
- iopamidol: 16.4%
- iopromide: 0.3%
- iotrolan: 27.5%
- ioversol
- ioxaglate
- ioxilan
- ipratropium bromide: common, 0% - 9.8%
- irbesartan: postmarketing, 7.9% - 16.1%
- irbesartan-hydrochlorothiazide: 9.3% - 16.1%
- irinotecan: 0.7% - 17%
- iron sucrose: 7.7% - 12.6%
- isocarboxazid
- isomannide
- isopropyl unoprostone
- isoproterenol
- isosorbide dinitrate
- isosorbide-5-mononitrate
- isradipine: 9.4% - 13.7%
- itraconazole: postmarketing, 0% - 6%
- ivabradine
- ivacaftor: 17% - 23.9%
- ivermectin: 1% - 18%
- ixabepilone: 0% - 11%
- kanamycin
- ketoconazole
- ketoprofen
- ketorolac: 17%
- ketorolac tromethamine: postmarketing, 0.641% - 17%
- ketotifen
- labetalol: 1% - 8%
- lacosamide: 4% - 16%
- lamivudine: common, 5% - 42%
- lamotrigine: 1.1% - 29.1%
- lanreotide
- lansoprazole: postmarketing, 0% - 14.9%
- lanthanum carbonate: 5% - 21%
- lapatinib: common, very common, 0% - 13%
- lasofoxifene: uncommon
- latanoprost
- leflunomide: postmarketing, common, 7% - 21%
- lenalidomide: postmarketing, very common, 14.5%
- lercanidipine: uncommon, common, 4.3% - 4.4%
- letrozole: common, 0.204% - 20.1%
- leuprorelin acetate: 2% - 31.9%
- levetiracetam: 1.19% - 19%
- levobunolol
- levocabastine: 5%
- levodopa/carbidopa: 2%
- levonorgestrel: postmarketing, 5.6% - 20.2%
- levosimendan
- lidocaine
- linaclotide: 4%
- linagliptin
- lindane: postmarketing
- linezolid: 0% - 8.8%
- liraglutide: postmarketing, 9.1% - 9.3%
- lisdexamfetamine dimesylate: postmarketing
- lisuride
- lithium
- lithium carbonate
- lodoxamide: 1.5%
- lodoxamide tromethamine: 1.5%
- lomefloxacin: 3.6%
- lomitapide
- loperamide
- loratadine: 4.66% - 8.33%
- lorazepam: infrequent, 1.18% - 1.25%
- lorcaserin: 14.5% - 16.8%
- lormetazepam
- losartan: 14.1%
- loteprednol etabonate: 1.5%
- lovastatin: 2.1% - 3.2%
- loxapine
- lubiprostone: 2% - 11%
- lymecycline
- mTHPC
- macitentan: 13.6% - 14%
- malvidin: 5.6% - 17%
- mannitol: 0.952% - 5.64%
- maprotiline: 4%
- maraviroc
- mebeverine
- medroxyprogesterone: 9% - 16.5%
- medroxyprogesterone acetate: 8% - 17%
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 0% - 10%
- melatonin
- meloxicam: 0% - 9.3%
- memantine: 5.02% - 6%
- meperidine
- mepivacaine
- meprobamate
- meropenem: 0.5% - 7.8%
- mesna: 3-11% - 50%
- metaiodobenzylguanidine: 0.4%
- metaproterenol: 7% - 35%
- metaxalone
- metformin: 4.7% - 5.7%
- methacholine
- methadone
- methamphetamine
- methazolamide
- methimazole
- methocarbamol
- methohexital
- methotrexate
- methsuximide
- methyclothiazide
- methyl aminolevulinate
- methyldopa
- methylene blue
- methylergometrine
- methylphenidate: postmarketing, common, 0.6% - 39%
- methylprednisolone
- methylprednisolone sodium succinate
- methyltestosterone
- metipranolol
- metoclopramide: postmarketing
- metolazone: 9.3%
- metoprolol: postmarketing, common
- metronidazole: very rare, postmarketing, 0.529% - 18%
- metyrapone: common
- mexiletine: 4.3% - 7.7%
- mianserin: common
- miconazole: 1.3% - 7.6%
- midazolam: 1.3% - 1.5%
- midodrine: uncommon
- mifepristone: 44%
- miglustat: 15% - 22%
- milnacipran: 17% - 19%
- milrinone
- minocycline: 7.2% - 22.6%
- mipomersen: 12%
- mirabegron: 0.6% - 4.1%
- mirtazapine: postmarketing
- misoprostol: 2.4%
- mitomycin C
- mitotane
- mitoxantrone: 6% - 13%
- moclobemide
- modafinil: postmarketing, 1% - 23%
- moexiprilat
- mometasone: 1.96% - 26%
- mometasone furoate: 8% - 22%
- monamine
- montelukast: 18.4%
- morphine: postmarketing
- moxifloxacin: 2%
- moxonidine: postmarketing
- mupirocin: 1.7% - 9%
- mycophenolate mofetil: 2.7% - 54.3%
- mycophenolic acid: 11% - 54.3%
- nabilone: postmarketing, 0% - 8%
- nabumetone: 8%
- naftifine: postmarketing
- nalbuphine: 3%
- nalidixic acid
- nalmefene: 1%
- naltrexone: postmarketing, 1% - 7%
- naphazoline
- naproxen: postmarketing, 15%
- naratriptan
- nebivolol: 0.4% - 9%
- nedocromil sodium: 5%
- nefazodone
- nefopam
- nelarabine: 0% - 17%
- nelfinavir
- neostigmine
- nepafenac
- nesiritide: 7% - 20%
- nevirapine: common, 0.7% - 4%
- niacin
- nicardipine: 2.5% - 15%
- nicorandil: uncommon, very common
- nicotine: 3.3% - 18%
- nifedipine: 3.1% - 23%
- nilotinib: 1% - 22%
- nilutamide
- nimodipine: 0% - 4.1%
- nisoldipine: 22%
- nitazoxanide: 1.1% - 3.1%
- nitrazepam
- nitric oxide: postmarketing
- nitrofurantoin: 6%
- nitroglycerin: very rare, common, 3% - 63%
- nitroprusside
- nitrous oxide
- nizatidine: 4.6% - 16.6%
- norepinephrine
- norethisterone
- norfloxacin: 1.6% - 2.8%
- nortriptyline
- ofatumumab: 0% - 7%
- ofloxacin: 0% - 0.3%
- ogen
- olanzapine: 13% - 18%
- olmesartan: postmarketing, common, 0% - 7.53%
- olmesartan medoxomil
- olopatadine: postmarketing, 4.05% - 4.43%
- olsalazine: 3% - 5%
- omeprazole: common, 1.9% - 10.9%
- ondansetron: very common, 5.83% - 27.2%
- orlistat: common, 30.6%
- orphenadrine
- oseltamivir: postmarketing, 1.8% - 13%
- oxaliplatin: 1% - 13%
- oxaprozin
- oxazepam
- oxcarbazepine: very common, 1.4% - 32%
- oxprenolol
- oxybutynin: common, 1.5% - 8%
- oxycodone: 6% - 8%
- oxymorphone: 2.9% - 12.2%
- oxytocin injection
- paclitaxel: very rare, postmarketing, common
- paliperidone: very common, 4% - 14%
- palonosetron: 3.27% - 16.5%
- pamidronate: common, 0% - 27.2%
- pantoprazole: common, 1% - 24%
- papaverine
- paricalcitol: 2% - 5%
- paroxetine: postmarketing, common, 0.3% - 27%
- pazopanib: 0% - 23%
- pegaptanib
- pegaptanib sodium
- pemirolast
- penbutolol: 0.4% - 7.8%
- penciclovir: postmarketing, 8.5% - 39.3%
- penicillin
- pentamidine
- pentazocine
- pentobarbital
- pentosan polysulfate: 1% - 3%
- pentostatin: 13% - 29%
- pentoxifylline: 1.2% - 6.2%
- perampanel: 11% - 13%
- pergolide: frequent, 5.3%
- perhexiline
- perindopril: 23.8%
- perindopril erbumine: 3% - 26%
- perindoprilat
- permethrin
- perphenazine
- phendimetrazine
- phenelzine
- phenobarbital
- phentermine
- phentolamine: 0% - 3.9%
- phenylazo
- phenylbutyric acid
- phenylephrine
- phenytoin: 2.2% - 8.9%
- phosphate
- pilocarpine: 11% - 13%
- pimecrolimus: 7.01% - 25.4%
- pimozide: postmarketing, 1% - 22.2%
- pinaverium bromide: 0.3%
- pindolol
- pioglitazone: 2.8% - 9.1%
- piperacillin
- pirbuterol: 1.3% - 2%
- pirfenidone
- piroxicam: 4.1%
- pitavastatin
- pixantrone
- pizotifen
- podophyllotoxin: 7%
- polymyxin B
- polythiazide
- pomalidomide: 8.04% - 13.1%
- ponatinib: 0% - 39%
- posaconazole: 6% - 19.7%
- potassium phosphate
- pralidoxime
- pramipexole: postmarketing, common, 4% - 16.2%
- prasugrel: 5.3% - 5.5%
- pravastatin: 1.7% - 6.3%
- praziquantel
- prazosin: 8%
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin: postmarketing, 4.2% - 12%
- primidone
- probenecid
- procarbazine
- prochlorperazine
- progesterone: postmarketing, 3.22% - 30%
- proguanil
- promethazine
- propafenone: postmarketing, 0.8% - 10.3%
- propantheline
- propofol
- propoxyphene
- propoxyphene napsylate
- propylthiouracil
- prostacyclin: 5% - 83%
- protriptyline
- prucalopride: very common
- pyrantel
- pyridostigmine
- pyridoxine
- quazepam: 5%
- quetiapine: 6.2% - 21%
- quinapril: 1.7%
- quinaprilat: 1.7%
- quinidine: 3% - 18%
- rabeprazole: 5% - 9.9%
- raloxifene: 9.2%
- raltegravir: 2% - 9.7%
- raltitrexed: 2-3%
- ramelteon: 0.3% - 7%
- ramipril: 0.1% - 15.1%
- ramiprilat: 5.4%
- ranitidine: 4%
- ranolazine: 2.63% - 5.5%
- rapamycin: 10% - 34%
- rasagiline: 6% - 14%
- rasburicase: 0% - 26%
- reboxetine: 14.8%
- regadenoson: very common, 17% - 27%
- regorafenib: 10% - 16%
- remifentanil: 0% - 17.6%
- repaglinide: 8% - 9%
- rescinnamine: 2.8%
- reserpine
- retapamulin: 1.2% - 2%
- retinoic acid: postmarketing, 29-90% - 86%
- ribavirin: very common, 1% - 69%
- rifabutin: 3%
- rifampicin
- rifapentine
- rifaximin: 9.69%
- rilpivirine: 3% - 4%
- riluzole: 7% - 8%
- rimantadine: 1.3% - 1.4%
- rimexolone
- rimonabant: postmarketing
- riociguat: 27%
- risedronate: 2.6% - 18%
- risperidone: 3% - 22.4%
- ritonavir: 5.1% - 7.8%
- rivaroxaban
- rivastigmine: common, 1% - 17%
- rizatriptan: 2%
- rofecoxib: 4.7% - 8%
- roflumilast: 1.7% - 4.39%
- ropinirole: 0.8% - 17%
- ropivacaine: 2.3% - 8.1%
- rosiglitazone: 5.4% - 20%
- rosuvastatin: common, 3.1% - 8.5%
- rotigotine: 10% - 21%
- roxithromycin
- rufinamide: 2% - 27%
- ruxolitinib: very common, 0% - 14.8%
- sacrosidase
- salbutamol: postmarketing, common, 1.5% - 35%
- salicylate
- salmeterol: common, 4.24% - 20%
- salmon calcitonin acetate: postmarketing, common, 3% - 4.6%
- saquinavir: common
- scopolamine: postmarketing
- secobarbital
- sertraline: postmarketing, rare, common, 1% - 26%
- sevelamer hydrochloride: 9.1% - 15.8%
- sevoflurane
- sibutramine
- sildenafil: postmarketing, very common, 4% - 49%
- silodosin: 2.36%
- simvastatin: 1% - 7.4%
- sitagliptin: postmarketing, common, 1.12% - 3.85%
- sitaxsentan: very common, 15.4%
- sodium
- sodium acetate
- sodium cromoglycate
- sodium ferric gluconate: 7% - 24%
- sodium iothalamate
- sodium nitroprusside
- sodium tetradecyl sulphate
- sofosbuvir: very common, 20% - 44%
- solifenacin: postmarketing
- sorafenib: postmarketing, 0% - 10%
- sotalol: 1% - 11.5%
- sparfloxacin: 4.2% - 8.1%
- spironolactone
- stavudine: 49% - 54%
- strontium ranelate
- sufentanil
- sugammadex
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 9%
- sulindac
- sumatriptan: 1% - 2%
- sunitinib
- suvorexant: 7%
- tacrolimus: very common, 5% - 64%
- tadalafil: 3% - 42%
- tafluprost: 6%
- tamoxifen: postmarketing, 8.05% - 10.2%
- tamsulosin: postmarketing, uncommon, 0.4% - 21.1%
- tapentadol: postmarketing, 10% - 15%
- tasimelteon: 17%
- technetium-99m: 0.169% - 1.63%
- teduglutide: 17%
- tegaserod: 15%
- telavancin: common
- telithromycin: 1.5% - 5.8%
- telmisartan: postmarketing, very common, 8%
- temazepam: 8.5% - 9.1%
- temozolomide: very common, 1.74% - 41.1%
- temsirolimus
- teniposide
- tenofovir: 5% - 8%
- tenofovir disoproxil fumarate: 5% - 14%
- tenoxicam: common
- terazosin: 1.1% - 16.2%
- terbinafine: common, 0.2% - 12.9%
- terbutaline: 3.3% - 9.8%
- terconazole: 26%
- testosterone: postmarketing, 0% - 6%
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine
- tetraen
- tetrahydrobiopterin: 14.9%
- tetrahydrozoline
- tetrofosmin: 14%
- thalidomide: 0% - 22.5%
- theophylline
- thiabendazole
- thiazide
- thioridazine
- thiosulfate
- thiotepa: 1-10%
- thymidine: 1% - 14%
- thyroxine
- tiagabine
- tiaprofenic acid: 2.9% - 3.4%
- tibolone
- ticagrelor: 5.8% - 6.5%
- ticlopidine
- tigecycline: common, 5.9% - 7%
- tiludronate
- timolol: 1.7%
- tinidazole: 0.7% - 1.3%
- tiotropium
- tipranavir: common, 4.2%
- tirofiban: 1.1%
- tobramycin: uncommon, 11.4% - 26.7%
- tofacitinib: 3.4% - 4.3%
- tolazamide
- tolbutamide
- tolcapone: 10%
- tolmetin
- tolterodine: 1% - 3.7%
- tolvaptan: common
- topiramate: postmarketing, rare, 1% - 29%
- topotecan: common, 0% - 18%
- torasemide: 7.3%
- toremifene
- trabectedin
- tramadol: common, 2.83% - 32%
- tramazoline
- trametinib: 0% - 37%
- trandolapril: 2.3% - 4.9%
- trandolaprilat
- tranexamic acid: 50.4%
- trans 4-cyclohexyl-L-proline
- tranylcypromine
- travoprost: uncommon, common, 0.3% - 1.4%
- trazodone: 0.99% - 33.2%
- treprostinil: 27% - 63%
- triamcinolone: 6.2% - 51%
- triamcinolone acetonide: 0.7% - 15.4%
- triamterene
- triazolam: 9.7%
- trifluoperazine
- trihexyphenidyl
- trimethadione
- trimethobenzamide
- trimethoprim: common
- trimethoprim-sulfamethoxazole: common
- trimipramine
- tropicamide
- tropisetron: 2.3% - 9.66%
- trospium chloride: 4.2% - 4.23%
- trovafloxacin: 1% - 5%
- ulipristal: 18% - 19%
- umeclidinium
- unoprostone
- ustekinumab: common, 5%
- v 1784: postmarketing, very common, 1% - 25%
- valdecoxib: 4.3% - 6.6%
- valganciclovir: 5% - 27%
- valproate: 2.7% - 39%
- valrubicin
- valsartan: 8.5%
- vandetanib: 1% - 26%
- vardenafil: 0.9% - 15%
- varenicline: 15% - 19%
- vemurafenib: postmarketing, 0% - 27%
- venlafaxine: postmarketing, very common, 1% - 38%
- verapamil: 1.2% - 12.1%
- vernakalant
- verteporfin
- vigabatrin: common, 26% - 33%
- vildagliptin: uncommon, common
- vinblastine
- vincristine
- vinflunine
- vinorelbine: postmarketing, 5%
- voriconazole: very common, 0% - 4.32%
- vorinostat
- warfarin
- x M22
- zafirlukast: 12.9%
- zalcitabine
- zaleplon: 30% - 42%
- zanamivir: 2% - 24%
- ziconotide: 12% - 13%
- zidovudine: very common, 8.5% - 63%
- zidovudine/lamivudine: 27% - 35.1%
- zileuton: 23%
- ziprasidone: 1.8% - 18%
- zoledronic acid: postmarketing, common, 3.9% - 20.4%
- zolmitriptan: postmarketing, rare
- zolpidem: postmarketing, common, frequent, 0.4% - 19%
- zonisamide: 10%
- zopiclone: 13% - 21%
- zuclopenthixol
|
Drugs with this indication
|
